|
Market Closed -
Other stock markets
|
After hours 07:56:02 pm | |||
| 267.47 USD | -5.54% |
|
268.23 | +0.28% |
Insider Transaction History
Latest insider transactions for Alnylam Pharmaceuticals, Inc.
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 6/1/26 | Free | Director | 4,393 | 303.64 | 1.33M | 0.0033% | ||
| 6/1/26 | Fiscal year | Director | 11,490 | 149.59 | 1.15M | 0.0086% | ||
| 5/20/26 | Free | Director | 2,112 | - | - | 0.0016% | ||
| 5/20/26 | Free | Director | 2,112 | - | - | 0.0016% | ||
| 5/20/26 | Free | Director | 2,112 | - | - | 0.0016% | ||
| 5/20/26 | Free | Director | 2,112 | - | - | 0.0016% | ||
| 5/20/26 | Free | Director | 2,112 | - | - | 0.0016% | ||
| 5/20/26 | Free | Chairman | 2,640 | - | - | 0.0020% | ||
| 5/20/26 | Free | Director | 2,112 | - | - | 0.0016% | ||
| 5/20/26 | Free | Director | 2,112 | - | - | 0.0016% | ||
| 5/20/26 | Free | Director | 2,112 | - | - | 0.0016% | ||
| 5/13/26 | Fiscal year | Chairman | 22,500 | 70.20 | 790K | 0.0169% | ||
| 4/2/26 | Sell | Head of Human Resources | 3,910 | 325.92 | 1.27M | 0.0029% | ||
| 3/25/26 | Other | Head of Human Resources | 16,920 | - | - | 0.0128% | ||
| 3/4/26 | Sell | Chief Executive Officer | 2,933 | 323.08 | 948K | 0.0022% | ||
| 3/4/26 | Sell | Chief Technology Officer | 4,713 | 323.53 | 1.52M | 0.0036% | ||
| 3/4/26 | Sell | Chief Financial Officer | 2,468 | 323.08 | 797K | 0.0019% | ||
| 3/4/26 | Sell | Executive/Senior Manager | 2,309 | 323.08 | 746K | 0.0017% | ||
| 3/4/26 | Sell | Chief Technology Officer | 1,291 | 323.54 | 418K | 0.0010% | ||
| 3/2/26 | Free | Executive/Senior Manager | 16,847 | 82.23 | 524K | 0.0127% | ||
| 3/2/26 | Free | Chief Financial Officer | 17,455 | 103.63 | 723K | 0.0132% | ||
| 3/2/26 | Free | Chief Technology Officer | 18,741 | 136.80 | 1.13M | 0.0141% | ||
| 3/2/26 | Free | General Counsel | 4,920 | - | - | 0.0037% | ||
| 3/2/26 | Free | Chief Technology Officer | 15,043 | 151.60 | 1.05M | 0.0113% | ||
| 3/2/26 | Free | Chief Executive Officer | 161,814 | 107.92 | 2.23M | 0.1220% | ||
| 2/27/26 | Fiscal year | Chief Executive Officer | 11,842 | - | - | 0.0090% | ||
| 2/27/26 | Fiscal year | Executive/Senior Manager | 3,332 | - | - | 0.0025% | ||
| 2/27/26 | Fiscal year | Chief Technology Officer | 8,443 | 234.60 | 1.53M | 0.0064% | ||
| 2/27/26 | Fiscal year | Chief Financial Officer | 3,816 | - | - | 0.0029% | ||
| 2/23/26 | Free | Chief Technology Officer | 158 | - | - | 0.0001% | ||
| 2/12/26 | Free | Executive/Senior Manager | 5,959 | 101.94 | 607K | 0.0045% | ||
| 2/12/26 | Free | Chief Financial Officer | 6,821 | 101.92 | 695K | 0.0052% | ||
| 2/12/26 | Free | Chief Executive Officer | 21,167 | 101.93 | 2.16M | 0.0160% | ||
| 2/12/26 | Free | Chief Technology Officer | 8,000 | 160.62 | 1.28M | 0.0061% | ||
| 2/12/26 | Free | Chief Technology Officer | 6,821 | 101.92 | 695K | 0.0052% | ||
| 1/11/26 | Free | Chief Technology Officer | 7,600 | 183.68 | 1.4M | 0.0058% | ||
| 1/11/26 | Free | Chief Financial Officer | 8,973 | 112.42 | 1.01M | 0.0068% | ||
| 1/11/26 | Free | Chief Executive Officer | 28,580 | 121.59 | 3.48M | 0.0216% | ||
| 1/11/26 | Free | Executive/Senior Manager | 5,310 | 103.19 | 548K | 0.0040% | ||
| 1/11/26 | Free | Chief Technology Officer | 5,310 | 103.19 | 548K | 0.0040% | ||
| 1/5/26 | Free | Director | 3,279 | - | - | 0.0025% | ||
| 11/26/25 | Fiscal year | Chief Executive Officer | 10,515 | 171.66 | 999K | 0.0080% | ||
| 11/17/25 | Fiscal year | Chief Technology Officer | 28,450 | 318.21 | 6.46M | 0.0217% | ||
| 11/12/25 | Fiscal year | Chief Executive Officer | 76,950 | 284.96 | 14.62M | 0.0587% | ||
| 10/1/25 | Free | Chief Technology Officer | 7,394 | 149.24 | 1.1M | 0.0057% | ||
| 10/1/25 | Free | Executive/Senior Manager | 4,256 | 149.23 | 635K | 0.0033% | ||
| 10/1/25 | Free | Chief Financial Officer | 11,573 | 149.25 | 1.73M | 0.0089% | ||
| 10/1/25 | Free | Chief Executive Officer | 27,036 | 149.21 | 4.03M | 0.0209% | ||
| 10/1/25 | Free | Chief Technology Officer | 11,918 | 225.88 | 2.69M | 0.0092% | ||
| 10/1/25 | Free | General Counsel | 13,026 | - | - | 0.0101% | ||
- Stock Market
- Stocks
- ALNY Stock
- Company Alnylam Pharmaceuticals, Inc.
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
















